In a Cochrane review of 11 studies, which included 9839 participants with stable chronic COPD, LAMA+LABA treatment had fewer exacerbations, a larger improvement of FEV1, a lower risk of pneumonia, and more frequent improvement in quality of life as measured by an increase over 4 units or more of the St. George’s Respiratory Questionnaire (SGRQ) compared with LABA+ICS Continue Reading »
The inhaler technique videos below have been jointly produced by PrescQIPP and Health and Care Videos to help patients, carers and others master any one of 17 different inhalers. A range of patient information leaflet templates to support the videos will be available soon. Click here to go to the videos.
This PrescQIPP bulletin focuses on frailty and end of life and the specific considerations that would apply to this group of patients when reviewing medicines or considering stopping medicines. Medicines that should usually be continued and those with increased potential to cause harm are highlighted in the full bulletin with evidence-based tools to help the review process.